Multiple Sclerosis

MS Patients on Ocrelizumab May Have Lessened Immune Response to SARS-CoV-2

April 21st 2021, 2:00pm


In an abstract presented at this year’s American Academy of Neurology annual meeting, patients with multiple sclerosis (MS) taking ocrelizumab had less of an immune reaction to infection with SARS-CoV-2, the virus that causes COVID-19.

DMT Alone Not a Good Predictor of COVID-19 Among Patients With MS

April 19th 2021, 3:30pm


Compared with disease-modifying therapy (DMT), age, insurance status, and Hispanic ethnicity were shown to more accurately predict likelihood of COVID-19 and hospitalization from it among individuals with multiple sclerosis (MS).

DMD Decision Aid Tool for Patients With MS Runs Into Efficacy Challenges

April 16th 2021, 4:33pm


An online tool developed to facilitate efficient patient-provider decisions on disease modifying drugs for multiple sclerosis (MS) ran into several challenges and warrants further study.

Clinical Surveillance Remains Necessary Among Cladribine-Treated Patients With RRMS

April 13th 2021, 6:55pm


A prospective bicentric cohort study among individuals with relapsing-remitting multiple sclerosis (RRMS) showed that 32% developed at least 1 skin-related adverse reaction following cladribine administration.

Understanding the Patient Factors Linked to Fatigue in Multiple Sclerosis

April 10th 2021, 12:00pm


The advent of both new diagnostic criteria and treatments have necessitated a reevaluation of fatigue among individuals who have multiple sclerosis, investigators say.

Review Explores Health Literacy in Patients With MS

April 7th 2021, 6:58pm


Because health literacy can have different meanings for patients with different diseases, this review aimed to crystalize a definition in patients with multiple sclerosis (MS) and emphasize its importance in care planning.

Infection Risk May Increase With Fingolimod Use in Patients With MS

April 1st 2021, 11:00am


Among patients with multiple sclerosis, there is a 16% greater risk of infection, including for lower respiratory and herpes virus infections, after administration of fingolimod.

Transcranial Direct Current Stimulation May Benefit Patients With MS

March 30th 2021, 1:50pm


With most current therapies for patients with multiple sclerosis (MS) targeting disease progression, a recent review evaluated transcranial direct current stimulation’s ability to improve certain disease symptoms.

Researchers Identify 4 Distinct Phenotypes of Cognitive Impairment in MS

March 26th 2021, 9:04pm


Investigators aimed to close the knowledge gap on interindividual variability in cognitive evaluation outcomes by considering both cognitive impairment and mood disorders to better prediction accuracy.

Review Recommends Guidelines for Patients With MS Taking Herbal Drugs, Supplements

March 24th 2021, 6:49pm


With many patients with multiple sclerosis (MS) increasingly turning to herbal drugs and supplements to treat their disease, for which there is no cure, a recent review evaluated the safety of these alternative therapies.